Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

AMG 151 Amgen Protocol Number 20100761

ClinicalTrials.gov ID: NCT01464437

Public ClinicalTrials.gov record NCT01464437. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 3:50 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Explore Dose Effect and Frequency of Administration of AMG 151 in Subjects With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 2a, multicenter, randomized, double-blind, placebo-controlled, parallel group, fixed dose study. AMG 151 will be evaluated in subjects with type 2 diabetes treated with metformin for at least 3 months prior to randomization.

Study identification

NCT ID
NCT01464437
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Amgen
Industry
Enrollment
236 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2011 (Type not available)
Primary completion
Oct 2012 (Actual)
Completion
Dec 2012 (Actual)
Last update posted
May 13, 2014

2011 – 2012

United States locations

U.S. sites
65
U.S. states
23
U.S. cities
60
Facility City State ZIP Site status
Research Site Birmingham Alabama 35216 —
Research Site Phoenix Arizona 85021 —
Research Site Tucson Arizona 85704 —
Research Site Little Rock Arkansas 72205 —
Research Site Anaheim California 92801 —
Research Site Chula Vista California 91911 —
Research Site Fresno California 93720 —
Research Site Greenbrae California 94904 —
Research Site Inglewood California 90301 —
Research Site Lomita California 90717 —
Research Site Los Angeles California 90017 —
Research Site Los Angeles California 90057 —
Research Site Palm Desert California 92260 —
Research Site Roseville California 95661 —
Research Site San Diego California 92161 —
Research Site San Jose California 95123 —
Research Site Walnut Creek California 94598 —
Research Site Watsonville California 95076 —
Research Site Bradenton Florida 34208 —
Research Site Brooksville Florida 34601 —
Research Site Clearwater Florida 33756 —
Research Site Fort Myers Florida 33912 —
Research Site Kissimmee Florida 34741 —
Research Site Maitland Florida 32751 —
Research Site Palm Harbor Florida 34684 —
Research Site St. Petersburg Florida 33709 —
Research Site St. Petersburg Florida 33716 —
Research Site Tampa Florida 33606 —
Research Site Winter Park Florida 32789 —
Research Site Atlanta Georgia 30338 —
Research Site Columbus Georgia 31904 —
Research Site Dunwoody Georgia 30338 —
Research Site Roswell Georgia 30076 —
Research Site Meridian Idaho 83642 —
Research Site Chigago Illinois 60607 —
Research Site Indianapolis Indiana 46202 —
Research Site Metairie Louisiana 70006 —
Research Site Bethesda Maryland 20817 —
Research Site St Louis Missouri 63128 —
Research Site Bozeman Montana 59718 —
Research Site Las Vegas Nevada 89106 —
Research Site Las Vegas Nevada 89117 —
Research Site Mineola New York 11501 —
Research Site Raleigh North Carolina 27612 —
Research Site Shelby North Carolina 28150 —
Research Site Bismarck North Dakota 58503 —
Research Site Fargo North Dakota 58103 —
Research Site Cincinnati Ohio 45227 —
Research Site Cleveland Ohio 44122 —
Research Site Dayton Ohio 45439 —
Research Site Kettering Ohio 45429 —
Research Site Norman Oklahoma 73069 —
Research Site Oklahoma City Oklahoma 73112 —
Research Site Rapid City South Dakota 57702 —
Research Site Dallas Texas 75235 —
Research Site Dallas Texas 75247 —
Research Site Houston Texas 77029 —
Research Site Houston Texas 77074 —
Research Site San Antonio Texas 78229 —
Research Site Draper Utah 84020 —
Research Site Salt Lake City Utah 84124 —
Research Site Midlothian Virginia 23114 —
Research Site Norfolk Virginia 23510 —
Research Site Richmond Virginia 23219 —
Research Site Salem Virginia 24153 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01464437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2014 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01464437 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →